Pro: Impossible to successfully time the market

May 10, 2016

John Buckingham appeared on CNBC on May 10, 2016. John likes biotech stocks like Gilead and Amgen because they are trading at attractive valuations. If Hillary comes to power we will see what happens with the possibility of price controls and increased regulation. John already owns a sufficient amount of Apple, but if he didn’t, he would be a buyer today (May 10, 2016).

Click here to view the video.

About the Author

Christopher Quigley, CFA

Chris joined AFAM Capital in August of 2011 and Kovitz in 2018, as part of the Kovitz acquisition of AFAM. As a member of the investment team, Chris conducts fundamental research and analysis. He is responsible for identifying new investment opportunities and maintains company, industry, and macroeconomic models. Additionally, he is a regular contributor to the firm’s market commentary and newsletter. Chris earned a Bachelor of Arts degree in Economics from the University of Southern California in 2011. Chris is a CFA charterholder and a member of the CFA Society of Orange County.

Explore

Popular Posts

Gold in a Diversified Portfolio

December 18, 2024

Factor Investing as an Investment Strategy

July 9, 2024

Opinion: This is the most recommended US stock

June 5, 2017

10 Best Stocks for the Next 10 Years

March 15, 2015

Connect

Christopher Quigley, CFA

Subscribe For Free Stock Picks

Get expert investing tips and market insights delivered straight to your inbox.